XML 81 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Assumptions in its Application of the Black-scholes Option Pricing Model for Grants
The Company used the following assumptions in its application of the Black-Scholes option pricing model for grants during the year ended December 31, 2023 and 2022:
Year Ended December 31,
20232022
Weighted-average risk-free interest rate
3.46% - 4.80%
1.35% - 4.15%
Expected term (in years)
5.00 - 10.00
5.00 - 10.00
Expected dividend yield0%0%
Expected volatility
64.86% - 70.50%
64.67% - 78.12%
Summary of Stock Option Activity
The following table summarizes the stock option activity during the year ended December 31, 2023:
Number of
Options
Weighted-
Average
Exercise Price
per Share
Weighted
Average
Remaining
Contractual
Term (in Years)
Aggregate
Intrinsic Value
Outstanding as of December 31, 20223,559,041$7.36 
Granted2,411,6105.41 
Exercised(125,624)3.54 
Cancelled(348,630)8.10 
Outstanding as December 31, 20235,496,397$6.54 7.33$11,556,739 
Vested and exercisable at December 31, 20232,874,152$5.99 6.16$7,377,923 
Summary of Recognized Share-based Compensation Expense Recognized
For the years ended December 31, 2023 and 2022, the Company recognized share-based compensation expense on the accompanying consolidated statements of operations as follows:
Year Ended December 31,
20232022
Cost of revenue$— $9,703 
Research and development2,668,710 1,978,169 
General and administrative3,058,425 2,076,574 
Total$5,727,135 $4,064,446